Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for +publisher:"University of Michigan" +contributor:("Neamati, Nouri"). Showing records 1 – 8 of 8 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of Michigan

1. Lachacz, Eric. Developing Target Identification Platforms Using Profiled Kinase Inhibitors.

Degree: PhD, Medicinal Chemistry, 2017, University of Michigan

 Kinases are important enzymes in cellular signaling with their expression and activity tightly regulated. Dysregulated kinase activity can lead to numerous disease states such as… (more)

Subjects/Keywords: Profiled Kinase Inhibitor Libraries; Target Identification; Phenotypic Screening; Cancer; Fluorescent Microscopy; Machine Learning; Biological Chemistry; Molecular, Cellular and Developmental Biology; Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lachacz, E. (2017). Developing Target Identification Platforms Using Profiled Kinase Inhibitors. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/140900

Chicago Manual of Style (16th Edition):

Lachacz, Eric. “Developing Target Identification Platforms Using Profiled Kinase Inhibitors.” 2017. Doctoral Dissertation, University of Michigan. Accessed June 25, 2019. http://hdl.handle.net/2027.42/140900.

MLA Handbook (7th Edition):

Lachacz, Eric. “Developing Target Identification Platforms Using Profiled Kinase Inhibitors.” 2017. Web. 25 Jun 2019.

Vancouver:

Lachacz E. Developing Target Identification Platforms Using Profiled Kinase Inhibitors. [Internet] [Doctoral dissertation]. University of Michigan; 2017. [cited 2019 Jun 25]. Available from: http://hdl.handle.net/2027.42/140900.

Council of Science Editors:

Lachacz E. Developing Target Identification Platforms Using Profiled Kinase Inhibitors. [Doctoral Dissertation]. University of Michigan; 2017. Available from: http://hdl.handle.net/2027.42/140900


University of Michigan

2. Li, Yangbing. Development of novel PROTAC Small-Molecule Degraders of MDM2 Protein and Peptidomimetic Inhibitors Targeting WDR5-MLL1 Protein-Protein Interaction.

Degree: PhD, Medicinal Chemistry, 2018, University of Michigan

 The transcription factor p53 plays an important role in suppression of tumor development, as it is involved in several important regulation of cell process, such… (more)

Subjects/Keywords: MDM2 PROTAC; Molecular glue; WDR5 Inhibitor; Science (General); Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Li, Y. (2018). Development of novel PROTAC Small-Molecule Degraders of MDM2 Protein and Peptidomimetic Inhibitors Targeting WDR5-MLL1 Protein-Protein Interaction. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/145791

Chicago Manual of Style (16th Edition):

Li, Yangbing. “Development of novel PROTAC Small-Molecule Degraders of MDM2 Protein and Peptidomimetic Inhibitors Targeting WDR5-MLL1 Protein-Protein Interaction.” 2018. Doctoral Dissertation, University of Michigan. Accessed June 25, 2019. http://hdl.handle.net/2027.42/145791.

MLA Handbook (7th Edition):

Li, Yangbing. “Development of novel PROTAC Small-Molecule Degraders of MDM2 Protein and Peptidomimetic Inhibitors Targeting WDR5-MLL1 Protein-Protein Interaction.” 2018. Web. 25 Jun 2019.

Vancouver:

Li Y. Development of novel PROTAC Small-Molecule Degraders of MDM2 Protein and Peptidomimetic Inhibitors Targeting WDR5-MLL1 Protein-Protein Interaction. [Internet] [Doctoral dissertation]. University of Michigan; 2018. [cited 2019 Jun 25]. Available from: http://hdl.handle.net/2027.42/145791.

Council of Science Editors:

Li Y. Development of novel PROTAC Small-Molecule Degraders of MDM2 Protein and Peptidomimetic Inhibitors Targeting WDR5-MLL1 Protein-Protein Interaction. [Doctoral Dissertation]. University of Michigan; 2018. Available from: http://hdl.handle.net/2027.42/145791

3. Gasparyan, Mari. Meox1 Regulates Proliferation and Metastasis of Drug Resistant P53 and PTEN Deficient Triple Negative Breast Cancer Offering a Specific Therapeutic Target.

Degree: PhD, Pharmaceutical Sciences, 2018, University of Michigan

 Relative to other breast cancer subtypes, triple negative breast cancer (TNBC) exhibits more aggressive clinical behavior and poorer patient outcome. Lacking specified targets to improve… (more)

Subjects/Keywords: targeting triple negative breast cancer; tumor suppressor genes p53 and PTEN; chemotherapy and drug resistance; proliferation and metastasis; Molecular, Cellular and Developmental Biology; Science (General); Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gasparyan, M. (2018). Meox1 Regulates Proliferation and Metastasis of Drug Resistant P53 and PTEN Deficient Triple Negative Breast Cancer Offering a Specific Therapeutic Target. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/145898

Chicago Manual of Style (16th Edition):

Gasparyan, Mari. “Meox1 Regulates Proliferation and Metastasis of Drug Resistant P53 and PTEN Deficient Triple Negative Breast Cancer Offering a Specific Therapeutic Target.” 2018. Doctoral Dissertation, University of Michigan. Accessed June 25, 2019. http://hdl.handle.net/2027.42/145898.

MLA Handbook (7th Edition):

Gasparyan, Mari. “Meox1 Regulates Proliferation and Metastasis of Drug Resistant P53 and PTEN Deficient Triple Negative Breast Cancer Offering a Specific Therapeutic Target.” 2018. Web. 25 Jun 2019.

Vancouver:

Gasparyan M. Meox1 Regulates Proliferation and Metastasis of Drug Resistant P53 and PTEN Deficient Triple Negative Breast Cancer Offering a Specific Therapeutic Target. [Internet] [Doctoral dissertation]. University of Michigan; 2018. [cited 2019 Jun 25]. Available from: http://hdl.handle.net/2027.42/145898.

Council of Science Editors:

Gasparyan M. Meox1 Regulates Proliferation and Metastasis of Drug Resistant P53 and PTEN Deficient Triple Negative Breast Cancer Offering a Specific Therapeutic Target. [Doctoral Dissertation]. University of Michigan; 2018. Available from: http://hdl.handle.net/2027.42/145898


University of Michigan

4. Johnson, Oleta. Adaptation of Chemical Biology Approaches for Dissecting Disordered Protein Dynamics.

Degree: PhD, Chemical Biology, 2018, University of Michigan

 Proteins containing intrinsic disorder often undergo dynamic conformational change in response to ligand binding or post-translational modification. Chemical dissection of these dynamic protein perturbations presents… (more)

Subjects/Keywords: IDP; Intrinsically Disordered Proteins; Protein Dynamics; Chemistry; Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Johnson, O. (2018). Adaptation of Chemical Biology Approaches for Dissecting Disordered Protein Dynamics. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/147481

Chicago Manual of Style (16th Edition):

Johnson, Oleta. “Adaptation of Chemical Biology Approaches for Dissecting Disordered Protein Dynamics.” 2018. Doctoral Dissertation, University of Michigan. Accessed June 25, 2019. http://hdl.handle.net/2027.42/147481.

MLA Handbook (7th Edition):

Johnson, Oleta. “Adaptation of Chemical Biology Approaches for Dissecting Disordered Protein Dynamics.” 2018. Web. 25 Jun 2019.

Vancouver:

Johnson O. Adaptation of Chemical Biology Approaches for Dissecting Disordered Protein Dynamics. [Internet] [Doctoral dissertation]. University of Michigan; 2018. [cited 2019 Jun 25]. Available from: http://hdl.handle.net/2027.42/147481.

Council of Science Editors:

Johnson O. Adaptation of Chemical Biology Approaches for Dissecting Disordered Protein Dynamics. [Doctoral Dissertation]. University of Michigan; 2018. Available from: http://hdl.handle.net/2027.42/147481


University of Michigan

5. Maust, Joel. Combination Strategies for the Treatment of KRAS Mutant Colorectal and Pancreatic Cancer.

Degree: PhD, Pharmacology, 2018, University of Michigan

 A large percentage of human cancers show mutations in RAS, a critical activator of the mitogen activated protein kinase (MAPK) signaling cascade that has been… (more)

Subjects/Keywords: Co-targeting MEK and CDK4/6; colorectal cancer; pancreatic cancer; KRAS; Pharmacy and Pharmacology; Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Maust, J. (2018). Combination Strategies for the Treatment of KRAS Mutant Colorectal and Pancreatic Cancer. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/147596

Chicago Manual of Style (16th Edition):

Maust, Joel. “Combination Strategies for the Treatment of KRAS Mutant Colorectal and Pancreatic Cancer.” 2018. Doctoral Dissertation, University of Michigan. Accessed June 25, 2019. http://hdl.handle.net/2027.42/147596.

MLA Handbook (7th Edition):

Maust, Joel. “Combination Strategies for the Treatment of KRAS Mutant Colorectal and Pancreatic Cancer.” 2018. Web. 25 Jun 2019.

Vancouver:

Maust J. Combination Strategies for the Treatment of KRAS Mutant Colorectal and Pancreatic Cancer. [Internet] [Doctoral dissertation]. University of Michigan; 2018. [cited 2019 Jun 25]. Available from: http://hdl.handle.net/2027.42/147596.

Council of Science Editors:

Maust J. Combination Strategies for the Treatment of KRAS Mutant Colorectal and Pancreatic Cancer. [Doctoral Dissertation]. University of Michigan; 2018. Available from: http://hdl.handle.net/2027.42/147596


University of Michigan

6. Schmidt, Jennifer. Chemoenzymatic Assembly of Macrolactones: Merging Synthetic Chemistry with Biocatalysis to Afford Diverse Compound Libraries.

Degree: PhD, Medicinal Chemistry, 2018, University of Michigan

 Complex secondary metabolites display a wealth of biological activities and, together with their derivatives, have provided over 60% of new pharmaceutical agents over the past… (more)

Subjects/Keywords: Natural Product Biosynthesis; Chemical Biology; Organic Chemistry; Biological Chemistry; Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Schmidt, J. (2018). Chemoenzymatic Assembly of Macrolactones: Merging Synthetic Chemistry with Biocatalysis to Afford Diverse Compound Libraries. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/147609

Chicago Manual of Style (16th Edition):

Schmidt, Jennifer. “Chemoenzymatic Assembly of Macrolactones: Merging Synthetic Chemistry with Biocatalysis to Afford Diverse Compound Libraries.” 2018. Doctoral Dissertation, University of Michigan. Accessed June 25, 2019. http://hdl.handle.net/2027.42/147609.

MLA Handbook (7th Edition):

Schmidt, Jennifer. “Chemoenzymatic Assembly of Macrolactones: Merging Synthetic Chemistry with Biocatalysis to Afford Diverse Compound Libraries.” 2018. Web. 25 Jun 2019.

Vancouver:

Schmidt J. Chemoenzymatic Assembly of Macrolactones: Merging Synthetic Chemistry with Biocatalysis to Afford Diverse Compound Libraries. [Internet] [Doctoral dissertation]. University of Michigan; 2018. [cited 2019 Jun 25]. Available from: http://hdl.handle.net/2027.42/147609.

Council of Science Editors:

Schmidt J. Chemoenzymatic Assembly of Macrolactones: Merging Synthetic Chemistry with Biocatalysis to Afford Diverse Compound Libraries. [Doctoral Dissertation]. University of Michigan; 2018. Available from: http://hdl.handle.net/2027.42/147609


University of Michigan

7. Ouimet, Claire. Protein Cross-linking Capillary and Microchip Electrophoresis for Protein-Protein Interaction Analysis.

Degree: PhD, Chemistry, 2018, University of Michigan

 Proteins perform their functions as part of multi-protein complexes. These protein complexes are vital for carrying out and regulating cellular processes. As such, there is… (more)

Subjects/Keywords: Capillary Electrophoresis; Protein-Protein Interactions; Microfluidics; Chemistry; Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ouimet, C. (2018). Protein Cross-linking Capillary and Microchip Electrophoresis for Protein-Protein Interaction Analysis. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/147636

Chicago Manual of Style (16th Edition):

Ouimet, Claire. “Protein Cross-linking Capillary and Microchip Electrophoresis for Protein-Protein Interaction Analysis.” 2018. Doctoral Dissertation, University of Michigan. Accessed June 25, 2019. http://hdl.handle.net/2027.42/147636.

MLA Handbook (7th Edition):

Ouimet, Claire. “Protein Cross-linking Capillary and Microchip Electrophoresis for Protein-Protein Interaction Analysis.” 2018. Web. 25 Jun 2019.

Vancouver:

Ouimet C. Protein Cross-linking Capillary and Microchip Electrophoresis for Protein-Protein Interaction Analysis. [Internet] [Doctoral dissertation]. University of Michigan; 2018. [cited 2019 Jun 25]. Available from: http://hdl.handle.net/2027.42/147636.

Council of Science Editors:

Ouimet C. Protein Cross-linking Capillary and Microchip Electrophoresis for Protein-Protein Interaction Analysis. [Doctoral Dissertation]. University of Michigan; 2018. Available from: http://hdl.handle.net/2027.42/147636


University of Michigan

8. Clark, Jordan. Structural Investigation of Binding Events in Proteins.

Degree: PhD, Medicinal Chemistry, 2018, University of Michigan

 Understanding the biophysical properties that describe protein binding events has allowed for the advancement of drug discovery through structure-based drug design and in silico methodology.… (more)

Subjects/Keywords: Protein flexibility; Protein structure database; Protein-ligand binding; Protein-protein interaction (PPI); Biological Chemistry; Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Clark, J. (2018). Structural Investigation of Binding Events in Proteins. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/145943

Chicago Manual of Style (16th Edition):

Clark, Jordan. “Structural Investigation of Binding Events in Proteins.” 2018. Doctoral Dissertation, University of Michigan. Accessed June 25, 2019. http://hdl.handle.net/2027.42/145943.

MLA Handbook (7th Edition):

Clark, Jordan. “Structural Investigation of Binding Events in Proteins.” 2018. Web. 25 Jun 2019.

Vancouver:

Clark J. Structural Investigation of Binding Events in Proteins. [Internet] [Doctoral dissertation]. University of Michigan; 2018. [cited 2019 Jun 25]. Available from: http://hdl.handle.net/2027.42/145943.

Council of Science Editors:

Clark J. Structural Investigation of Binding Events in Proteins. [Doctoral Dissertation]. University of Michigan; 2018. Available from: http://hdl.handle.net/2027.42/145943

.